We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at ...

EGFR-TKI 已成为 EGFR 突变晚期非小细胞肺癌（NSCLC）患者的标准治疗方案[1]，然而，约 2%~5% 的初治 EGFR 突变晚期 NSCLC 患者合并原发 MET 扩增，且接受 EGFR-TKI ...

Each year, Phesi releases an analysis of the world’s most studied diseases. The survey includes data from the 67,569 ...

Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.

CStone Pharma announces inclusion of Cejemly as a first-line combination therapy for NSCLC in ESMO guideline: Suzhou, China Tuesday, February 11, 2025, 13:00 Hrs [IST] CStone Phar ...

As we approach another year of groundbreaking research in cancer care and significant treatment innovations, various companies are taking the ...

PRR15 作为一种在胎盘发育中起关键作用的核蛋白，此前在肿瘤研究领域关注度较低。虽有研究表明其在胃肠道肿瘤、乳腺癌和结肠腺癌等疾病中存在异常表达，但在 NSCLC 中的具体功能尚未明确。本研究旨在填补这一空白，深入剖析 PRR15 在 NSCLC 中的作用机制，为临床治疗提供新的思路和靶点。

The FDA granted breakthrough status to Serial CTRS, an AI tool that improves survival predictions in non–small cell lung ...

THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...

PROVIDENCE, RI - Ocean Biomedical (NASDAQ: OCEA) has announced research findings that show its immunotherapy candidates can work synergistically with tyrosine kinase inhibitors (TKIs), potentially ...

For patients with stage IA NSCLC, lung resections, including lobectomy and segmentectomy, are associated with improved long-term survival compared with wedge resection.